Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Bortezomib chemotherapy can cause temporary skin rashes.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.